Endometrial Stromal Sarcoma Overview

Save information for later
Sign Up

Learn About Endometrial Stromal Sarcoma

What is the definition of Endometrial Stromal Sarcoma?
Endometrial stromal sarcoma is a rare form of cancer that occurs due to abnormal and uncontrolled cell growth in the uterus. Endometrial stromal sarcoma, specifically, develops in the supporting connective tissue (stroma) of the uterus. Signs and symptoms of the condition include abnormal uterine bleeding (i.e. bleeding that is not part of menstrual periods or bleeding after menopause); abdominal pain and/or distension; and frequent urination. The exact underlying cause of Endometrial stromal sarcoma is currently unknown. Most cases occur sporadically in people with no family history of the condition.
What are the alternative names for Endometrial Stromal Sarcoma?
  • Endometrial stromal sarcoma
  • ESS
Who are the top Endometrial Stromal Sarcoma Local Doctors?
Distinguished in Endometrial Stromal Sarcoma
Dr. Alexander F. Burnett
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Distinguished in Endometrial Stromal Sarcoma
Dr. Alexander F. Burnett
Gynecologic Oncology | Oncology | Obstetrics and Gynecology

University Of Arkansas For Medical Sciences

4301 W Markham St, Suite 783, 
Little Rock, AR 
 (45.2 mi)
501-686-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Alexander Burnett is a Gynecologic Oncologist and an Oncologist in Little Rock, Arkansas. Dr. Burnett and is rated as a Distinguished provider by MediFind in the treatment of Endometrial Stromal Sarcoma. His top areas of expertise are Endometrial Cancer, Malignant Mixed Mullerian Tumor, Cervical Cancer, Hysterectomy, and Oophorectomy. Dr. Burnett is currently accepting new patients.

Distinguished in Endometrial Stromal Sarcoma
Dr. Monique A. Spillman
Gynecologic Oncology | Obstetrics and Gynecology
Distinguished in Endometrial Stromal Sarcoma
Dr. Monique A. Spillman
Gynecologic Oncology | Obstetrics and Gynecology

University Of Arkansas For Medical Sciences

4301 W Markham St, Suite 783, 
Little Rock, AR 
 (45.2 mi)
501-686-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Monique Spillman is a Gynecologic Oncologist and an Obstetrics and Gynecologist in Little Rock, Arkansas. Dr. Spillman and is rated as a Distinguished provider by MediFind in the treatment of Endometrial Stromal Sarcoma. Her top areas of expertise are Ovarian Cancer, Malignant Mixed Mullerian Tumor, Endometrial Cancer, Bladder Reconstruction, and Hysterectomy. Dr. Spillman is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Endometrial Stromal Sarcoma
Dr. Jamie L. Burton
Hematology Oncology | Hematology
Experienced in Endometrial Stromal Sarcoma
Dr. Jamie L. Burton
Hematology Oncology | Hematology

Central Arkansas Radiation Therapy Institute Inc

2605 College Ave, 
Conway, AR 
 (20.7 mi)
501-906-3000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jamie Burton is a Hematologist Oncology specialist and a Hematologist in Conway, Arkansas. Dr. Burton and is rated as an Experienced provider by MediFind in the treatment of Endometrial Stromal Sarcoma. Her top areas of expertise are Pleuropulmonary Blastoma, Breast Cancer, Choriocarcinoma, and Myelodysplastic Syndrome (MDS). Dr. Burton is currently accepting new patients.

View All Doctors
What are the latest Endometrial Stromal Sarcoma Clinical Trials?
A Phase II Study of Tailored Adjuvant Therapy in Pole-Mutated and p53-Wildtype/NSMP Early-Stage Endometrial Cancer (RAINBO BLUE &Amp; TAPER)
A Phase II Study of Tailored Adjuvant Therapy in Pole-Mutated and p53-Wildtype/NSMP Early-Stage Endometrial Cancer (RAINBO BLUE &Amp; TAPER)
Enrollment Status: Recruiting
Publish Date: January 31, 2025
Intervention Type: Procedure, Other, Radiation
Study Phase: Phase 2

Summary: This phase II trial tests how well tailoring therapy in post-surgery works in patients with low-risk endometrial cancer. The usual approach for patients with low-risk endometrial cancer is treatment with surgery. In this study, tissue that is removed as part of the surgical procedure is analyzed in the pathology laboratory to help guide the doctor to decide whether or not additional treatment such...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Randomized Comparative Prospective Multicentre Phase II Trial Evaluating Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic LGESS
Randomized Comparative Prospective Multicentre Phase II Trial Evaluating Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic LGESS
Who is this study for: Patients with Low Grade Endometrial Stromal Sarcoma
Enrollment Status: Recruiting
Publish Date: September 01, 2023
Intervention Type: Drug
Study Drug: Aromatase Inhibitors
Study Phase: Phase 2

Summary: The primary objective is to compare the progression-free survival (PFS) between aromatase inhibitors interruption and aromatase inhibitors maintenance strategies in patients with a locally advanced or metastatic Low Grade Endometrial Stromal Sarcoma (LGESS).

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center